PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $444,000 | +31.4% | 7,267 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -7.9% | 7,226 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $367,000 | +14.0% | 7,226 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $322,000 | -4.5% | 7,226 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $337,000 | +42.2% | 7,016 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $237,000 | -25.0% | 7,016 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $316,000 | -14.6% | 7,016 | -28.7% | 0.00% | 0.0% |
| Q1 2019 | $370,000 | +12.8% | 9,834 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $328,000 | -23.9% | 9,558 | +4.1% | 0.00% | 0.0% |
| Q3 2018 | $431,000 | +81.1% | 9,178 | +30.0% | 0.00% | +100.0% |
| Q2 2018 | $238,000 | +53.5% | 7,060 | -55.3% | 0.00% | 0.0% |
| Q1 2017 | $155,000 | -11.4% | 15,783 | -1.4% | 0.00% | -50.0% |
| Q4 2016 | $175,000 | -2.8% | 16,001 | +24.8% | 0.00% | 0.0% |
| Q3 2016 | $180,000 | +100.0% | 12,817 | -0.2% | 0.00% | +100.0% |
| Q2 2016 | $90,000 | – | 12,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |